Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · IEX Real-Time Price · USD
81.15
+0.24 (0.30%)
May 31, 2024, 4:00 PM EDT - Market closed
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for MMSI stock have an average target of 89.44, with a low estimate of 70 and a high estimate of 102. The average target predicts an increase of 10.22% from the current stock price of 81.15.
Analyst Consensus: Buy
* Price targets were last updated on May 1, 2024.
Analyst Ratings
The average analyst rating for MMSI stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 9 | 9 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 → $102 | Strong Buy | Maintains | $112 → $102 | +25.69% | May 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $98 → $100 | Buy | Maintains | $98 → $100 | +23.23% | May 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $95 → $97 | Buy | Maintains | $95 → $97 | +19.53% | May 1, 2024 |
| Needham | Needham | Strong Buy Maintains $88 → $85 | Strong Buy | Maintains | $88 → $85 | +4.74% | May 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $98 | Buy | Maintains | $98 | +20.76% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
1.35B
from 1.26B
Increased by 7.37%
Revenue Next Year
1.42B
from 1.35B
Increased by 5.48%
EPS This Year
3.40
from 1.62
Increased by 109.80%
EPS Next Year
3.71
from 3.40
Increased by 9.21%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.4B | 1.5B | 1.6B | 1.6B | 1.7B |
| Avg | 1.4B | 1.4B | 1.5B | 1.6B | 1.7B |
| Low | 1.3B | 1.4B | 1.4B | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.9% | 9.3% | 9.9% | 9.5% | 8.0% |
| Avg | 7.4% | 5.5% | 5.5% | 5.9% | 5.0% |
| Low | 2.8% | 0.5% | 0.1% | 1.3% | 0.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.52 | 3.97 | 4.36 | 4.82 | 5.21 |
| Avg | 3.40 | 3.71 | 4.09 | 4.42 | 5.06 |
| Low | 3.24 | 3.39 | 3.72 | 4.00 | 4.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 117.1% | 16.8% | 17.4% | 17.9% | 17.8% |
| Avg | 109.8% | 9.2% | 10.1% | 8.2% | 14.4% |
| Low | 100.2% | -0.2% | 0.3% | -2.2% | 9.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.